 SMC Global Securities Ltd Q2 FY2025-26 consolidated net profit declines to Rs. 20.65 crores
SMC Global Securities Ltd Q2 FY2025-26 consolidated net profit declines to Rs. 20.65 crores Rajoo Engineers Ltd Q2FY26 consolidated profit at Rs. 14.18 crores
Rajoo Engineers Ltd Q2FY26 consolidated profit at Rs. 14.18 crores Inventurus Knowledge Solutions Ltd consolidated Q2 FY2025-26 PAT climbs to Rs. 180.71 crores
Inventurus Knowledge Solutions Ltd consolidated Q2 FY2025-26 PAT climbs to Rs. 180.71 crores IFB Industries Ltd consolidated PAT for Q2FY26 jumps to Rs. 50.79 crores
IFB Industries Ltd consolidated PAT for Q2FY26 jumps to Rs. 50.79 crores Share India Securities Ltd consolidated Q2 FY26 net profit at Rs. 92.91 crores
Share India Securities Ltd consolidated Q2 FY26 net profit at Rs. 92.91 crores 
              The Board of Directors of Bal Pharma Ltd at its meeting held on April 13, 2016, has approved the allotment of 13,00,000 equity shares of Rs. 10/- each with a premium of Rs. 52/- per share of the Company on preferential basis to the investors who has exercised the conversion option on 13,00,000 warrants subscribed by them.
With this allotment, the paid up equity share capital of the Company has enhanced to Rs. 14,17,23,720/- divided into 1,41,72,372 equity shares of Rs. 10 each.
Shares of BAL PHARMA LTD. was last trading in BSE at Rs.103.7 as compared to the previous close of Rs. 102.1. The total number of shares traded during the day was 30464 in over 513 trades.
The stock hit an intraday high of Rs. 106.9 and intraday low of 102.6. The net turnover during the day was Rs. 3197216.